The Bard PowerFlow® Implantable Apheresis IV Port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for long-term therapeutic apheresis, withdrawal of blood, and infusion of medications, IV fluids, parenteral nutrition solutions, blood and blood products.
The Bard PowerFlow® Implantable Apheresis IV Port is indicated for power injection of contrast media.
For power injection of contrast media, the maximum recommended infusion rate is 5 mL/s.
This device is contraindicated for:
1. During Placement:
2. During Port Access:
I. Prior to Placement:
II. During Placement
III. After Placement:
NOT MADE WITH NATURAL RUBBER LATEX
Bard Access Systems, Inc.
605 North 5600 West
Salt Lake City, UT 84116 USA
Clinical Information Hotline:
Bard, PowerFlow and the radiopaque symbol are trademarks and/or registered trademarks of C. R. Bard, Inc. All other trademarks are the property of their respective owners. Copyright © 2017 C. R. Bard, Inc. All Rights Reserved.